Literature DB >> 8181470

Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.

G Siligardi1, B Samorí, S Melandri, M Visconti, A F Drake.   

Abstract

Calcitonin (CT) inhibits osteoclastic bone resorption and induces calcium uptake from body fluids. A comparative study of the conformational behaviours of therapeutic calcitonins [salmon (s), eel (e), a synthetic eel calcitonin analogue (Elcatonin), porcine (p) and human (h) calcitonins] as a function of solvent polarity and temperature have been performed by circular dichroism spectroscopy. Elements of secondary structure were lacking in H2O but could be observed in 2,2,2-trifluoroethanol and sodium dodecyl sulphate. In particular, similar amounts of alpha-helical content (four alpha-helical turns) were estimated in trifluoroethanol despite the considerable differences in amino acid sequences. The relative ability to form an alpha helix, assessed by trifluoroethanol/H2O titration, was found to be Elcatonin > sCT > pCT > eCT > hCT. In Elcatonin, sCT, pCT and eCT the four alpha-helical turns were promoted almost completely in a single step, between 0 and 35% trifluoroethanol, unlike hCT where helical structure formation has been reported to involve two steps over the whole trifluoroethanol/H2O range [Arvinte, T. & Drake, A. F. (1993) J. Biol. Chem. 268, 6408-6414]. In SDS, which mimics the membrane environment, conformational differences (3-4 helical turns in Elcatonin, sCT, eCT versus one helical turn in pCT, hCT) were observed and correlate well with biological activity (Elcatonin = sCT = eCT > pCT = hCT). Low-temperature studies in a cryogenic solvent mixture showed the formation of high alpha-helix content (similar to that in trifluoroethanol) in Elcatonin, sCT, eCT and pCT, whilst a left-handed extended helix (3(1) helix) was formed in hCT. This is consistent with the hypothesis of 'linear' and 'helical' calcitonin receptors [Nakanuta, H., Orlowski, R. C. & Epand, R. M. (1990) Endocrinology 127, 163-169].

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181470     DOI: 10.1111/j.1432-1033.1994.tb18832.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Scientific considerations for generic synthetic salmon calcitonin nasal spray products.

Authors:  Sau L Lee; Lawrence X Yu; Bing Cai; Gibbes R Johnsons; Amy S Rosenberg; Barry W Cherney; Wei Guo; Andre S Raw
Journal:  AAPS J       Date:  2010-10-30       Impact factor: 4.009

Review 2.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

3.  Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.

Authors:  Kian Kamgar-Parsi; Liu Hong; Akira Naito; Charles L Brooks; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

4.  Channel formation by salmon and human calcitonin in black lipid membranes.

Authors:  V Stipani; E Gallucci; S Micelli; V Picciarelli; R Benz
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

5.  Thermosensitive drug delivery system of salmon calcitonin: in vitro release, in vivo absorption, bioactivity and therapeutic efficacies.

Authors:  Yu Tang; Jagdish Singh
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

6.  The influence of phospholipid membranes on bovine calcitonin secondary structure and amyloid formation.

Authors:  Steven S-S Wang; Theresa A Good; Dawn L Rymer
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

7.  Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange.

Authors:  Yoshiaki Nabuchi; Yoshinori Asoh; Mitsuo Takayama
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

8.  Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study.

Authors:  Kerstin Wagner; Nicole Van Mau; Sylvie Boichot; Andrey V Kajava; Ulrike Krauss; Christian Le Grimellec; Annette Beck-Sickinger; Frédéric Heitz
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

9.  Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity.

Authors:  Weiqiang Cheng; Seetharama Satyanarayanajois; Lee-Yong Lim
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

Review 10.  The slowly aggregating salmon Calcitonin: a useful tool for the study of the amyloid oligomers structure and activity.

Authors:  Marco Diociaiuti; Maria Cristina Gaudiano; Fiorella Malchiodi-Albedi
Journal:  Int J Mol Sci       Date:  2011-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.